免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

NCT:NCT06310031 · RECRUITING

NCT编号NCT06310031
状态RECRUITING
开始日期2024-10-28
SponsorBrioHealth Solutions, Inc. (INDUSTRY)
First posted
Last updated

简要摘要

The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑